María-Belén Vidriales

Universidad de Salamanca

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (11)

ISABEL CANO FERRI

Instituto de Investigación Sanitaria La Fe

SPAIN

View details

Teresa Caballero-Velazquez

Profesor Contratado Doctor Vinculada

Universidad de Sevilla

SPAIN

View details

JAIME PEREZ DE OTEYZA

HEAD

SPAIN

View details

Rebeca Rodríguez-Veiga

Instituto de Investigación Sanitaria La Fe

SPAIN

View details

Sabrina Kraus

University Hospital Würzburg

GERMANY

View details

Juan Manuel Alonso-Dominguez

Universidad Autónoma de Madrid

SPAIN

View details

Miguel Sanz

Full Professor - Honorary Professor

University of Valencia

SPAIN

View details

Marta Rodriguez Gonzalez

University Hospital of Salamanca

SPAIN

View details

Jose A Martinez-Climent

Professor of Medicine

SPAIN

View details

MJ Calasanz

Full Professor of Genetics

Universidad de Navarra

SPAIN

View details

José Antonio Pérez-Simón

Universidad de Sevilla

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

María-Belén Vidriales

Research Interests

Explore related searches

Contact this professor

Articles (10)

Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups

Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory <i>FLT3</i>-ITD Mutation-Positive Acute Myeloid Leukemia

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia.

Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- And high-risk myeloma

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia.

Biological Features and Prognostic Impact of Bone Marrow Infiltration in Patients with Diffuse Large B-Cell Lymphoma.

Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols

Corrigendum to “Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study” [Leuk. Res. 92 (March) (2020) 106352] (Leukemia Research (2020) 92, (S0145212620300576), (10.1016/j.leukres.2020.106352))

Measurable residual disease by next-generation flow cytometry in multiple myeloma

Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study

Collaborators (11)

ISABEL CANO FERRI

Teresa Caballero-Velazquez

JAIME PEREZ DE OTEYZA

Rebeca Rodríguez-Veiga

Sabrina Kraus

Juan Manuel Alonso-Dominguez

Miguel Sanz

Marta Rodriguez Gonzalez

Jose A Martinez-Climent

MJ Calasanz

José Antonio Pérez-Simón

Make your next move.